生物制剂治疗鼻息肉型慢性鼻-鼻窦炎的临床缓解：一个为时过早的承诺？
Clinical remission in chronic rhinosinusitis with nasal polyps with biologics: a premature promise?
作者信息
Gelardi Matteo, Giancaspro Rossana
机构信息
Department of Otolaryngology, University of Foggia, Foggia, Italy.
Department of Otolaryngology, University of Foggia, Foggia, Italy
出版信息
Eur Respir Rev. 2025 Jul 9;34(177). doi: 10.1183/16000617.0093-2025. Print 2025 Jul.
Abstract
摘要
这看起来是一个网址链接，无法直接翻译为中文。它的意思是“https://bit.ly/4dvYC2I” 。
相似文献
1
Clinical remission in chronic rhinosinusitis with nasal polyps with biologics: a premature promise?生物制剂治疗鼻息肉型慢性鼻-鼻窦炎的临床缓解：一个为时过早的承诺？
Eur Respir Rev. 2025 Jul 9;34(177). doi: 10.1183/16000617.0093-2025. Print 2025 Jul.
2
Equivalent healthcare resource use following either a long-acting steroid-eluting implant or repeat endoscopic surgery for chronic rhinosinusitis patients with nasal polyp recurrence: a real-world evidence study.长效类固醇洗脱植入物或重复内镜手术治疗鼻息肉复发的慢性鼻窦炎患者后的等效医疗资源使用情况：一项真实世界证据研究
Curr Med Res Opin. 2025 May;41(5):767-777. doi: 10.1080/03007995.2025.2513955. Epub 2025 Jun 11.
3
Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis.鼻内用类固醇与安慰剂或不干预治疗慢性鼻-鼻窦炎的比较
Cochrane Database Syst Rev. 2016 Apr 26;4(4):CD011996. doi: 10.1002/14651858.CD011996.pub2.
4
Systemic and topical antibiotics for chronic rhinosinusitis.用于慢性鼻-鼻窦炎的全身及局部用抗生素
Cochrane Database Syst Rev. 2016 Apr 26;4(4):CD011994. doi: 10.1002/14651858.CD011994.pub2.
5
Efficacy and Safety of Biologics for Chronic Rhinosinusitis With Nasal Polyps: A Meta-Analysis of Real-World Evidence.生物制剂治疗伴鼻息肉慢性鼻-鼻窦炎的疗效与安全性：真实世界证据的Meta分析
Allergy. 2025 May;80(5):1256-1270. doi: 10.1111/all.16499. Epub 2025 Feb 22.
6
Chinese Position Paper on Biologic Therapy for Chronic Rhinosinusitis With Nasal Polyps.《中国鼻息肉慢性鼻窦炎生物治疗立场文件》
Allergy. 2025 May;80(5):1208-1225. doi: 10.1111/all.16519. Epub 2025 Mar 5.
7
Polymorphisms in chronic rhinosinusitis with nasal polyps - a systematic review.伴有鼻息肉的慢性鼻-鼻窦炎中的多态性——一项系统综述。
Braz J Otorhinolaryngol. 2017 Nov-Dec;83(6):705-711. doi: 10.1016/j.bjorl.2017.03.002. Epub 2017 Mar 23.
8
Short-course oral steroids as an adjunct therapy for chronic rhinosinusitis.短期口服类固醇作为慢性鼻-鼻窦炎的辅助治疗
Cochrane Database Syst Rev. 2016 Apr 26;4(4):CD011992. doi: 10.1002/14651858.CD011992.pub2.
9
Oral and intranasal aspirin desensitisation for non-steroidal anti-inflammatory drug (NSAID)-exacerbated respiratory disease.用于非甾体抗炎药（NSAID）诱发的呼吸道疾病的口服和鼻内阿司匹林脱敏疗法。
Cochrane Database Syst Rev. 2025 Jan 7;1(1):CD013476. doi: 10.1002/14651858.CD013476.pub2.
10
Short-course oral steroids alone for chronic rhinosinusitis.短期口服类固醇单独用于慢性鼻窦炎。
Cochrane Database Syst Rev. 2016 Apr 26;4(4):CD011991. doi: 10.1002/14651858.CD011991.pub2.
本文引用的文献
1
Con: clinical remission in asthma - not yet there.反对观点：哮喘的临床缓解——尚未实现。
Eur Respir Rev. 2025 Apr 2;34(176). doi: 10.1183/16000617.0182-2024. Print 2025 Apr.
2
Eosinophil-mast cell pattern of intraepithelial infiltration as a marker of severity in CRSwNP.上皮内浸润的嗜酸性粒细胞-肥大细胞模式作为 CRSwNP 严重程度的标志物。
Sci Rep. 2023 Jul 26;13(1):12101. doi: 10.1038/s41598-023-39149-8.
3
Correlation between chronic rhinosinusitis with nasal polyposis (CRSwNP) severity and asthma control.
Am J Otolaryngol. 2023 Mar-Apr;44(2):103701. doi: 10.1016/j.amjoto.2022.103701. Epub 2022 Nov 28.
4
Nasal-sinus polyposis: clinical-cytological grading and prognostic index of relapse.鼻-鼻窦炎：临床细胞学分级和复发的预后指数。
J Biol Regul Homeost Agents. 2009 Jul-Sep;23(3):181-8.
5
Inflammatory cell types in nasal polyps.鼻息肉中的炎症细胞类型。
Cytopathology. 2010 Jun;21(3):201-3. doi: 10.1111/j.1365-2303.2009.00671.x. Epub 2009 Sep 10.
Zotero 插件